{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:57:26Z","timestamp":1766066246005},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T00:00:00Z","timestamp":1349395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10,5]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Hyperthyroidism, defined by overproduction of thyroid hormones, has a 2\u20133% prevalence in the population. The most common form of hyperthyroidism is Graves' disease. A diagnostic biomarker for Graves' disease is the presence of immunoglobulins which bind to, and stimulate, the thyroid stimulating hormone receptor (TSHR), a G-protein coupled receptor (GPCR). We hypothesized that the ectopically expressed TSHR gene in a thyroid stimulating immunoglobulin (TSI) assay could be engineered to increase the accumulation of the GPCR pathway second messenger, cyclic AMP (cAMP), the molecule measured in the assay as a marker for pathway activation. An ectopically expressing TSHR-mutant guanine nucleotide-binding protein, (GNAS) Chinese hamster ovary (CHO) cell clone was constructed using standard molecular biology techniques. After incubation of the new clone with sera containing various levels of TSI, GPCR pathway activation was then quantified by measuring cAMP accumulation in the clone. The clone, together with a NaCl-free cell assay buffer containing 5% polyethylene glycol (PEG)6000, was tested against 56 Graves' patients, 27 toxic thyroid nodule patients and 119 normal patients. Using receiver operating characteristic analysis, when comparing normal with Graves' sera, the assay yielded a sensitivity of 93%, a specificity of 99% and an efficiency of 98%. Total complex precision (within-run, across runs and across days), presented as a percentage coefficient of variation, was found to be 7\u00b78, 8\u00b77 and 7\u00b76% for low, medium and high TSI responding serum, respectively. We conclude that the performance of the new TSI assay provides sensitive detection of TSI, allowing for accurate, early detection of Graves' disease.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2012.04648.x","type":"journal-article","created":{"date-parts":[[2012,7,14]],"date-time":"2012-07-14T03:55:50Z","timestamp":1342238150000},"page":"115-121","source":"Crossref","is-referenced-by-count":4,"title":["Measurement of thyroid stimulating immunoglobulins using a novel thyroid stimulating hormone receptor\u2013guanine nucleotide-binding protein, (GNAS) fusion bioassay"],"prefix":"10.1093","volume":"170","author":[{"given":"M","family":"Pierce","sequence":"first","affiliation":[{"name":"ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Sandrock","sequence":"additional","affiliation":[{"name":"Amgen, Thousand Oaks, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Gillespie","sequence":"additional","affiliation":[{"name":"ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A W","family":"Meikle","sequence":"additional","affiliation":[{"name":"ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT"},{"name":"Department of Endocrinology, Metabolism and Diabetes, University of Utah School of Medicine, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,10,5]]},"reference":[{"key":"2021122708262352800_b1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/BOR.0b013e3280113d1a","article-title":"Autoimmune thyroid diseases","volume":"19","author":"Caturegli","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"2021122708262352800_b2","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1172\/JCI26031","article-title":"Thyrotropin receptor-associated diseases: from adenomata to Graves disease","volume":"115","author":"Davies","year":"2005","journal-title":"J Clin Invest"},{"key":"2021122708262352800_b3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2265.2003.01681.x","article-title":"Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease","volume":"58","author":"Demers","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2021122708262352800_b4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122708262352800_b5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.autrev.2009.03.012","article-title":"TSH receptor autoantibodies","volume":"9","author":"Michalek","year":"2009","journal-title":"Autoimmun Rev"},{"key":"2021122708262352800_b6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/08916930410001705394","article-title":"Autoimmune thyroid disease","volume":"37","author":"Weetman","year":"2004","journal-title":"Autoimmunity"},{"key":"2021122708262352800_b7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3346\/jkms.2002.17.3.293","article-title":"Clinical applications of TSH receptor antibodies in thyroid diseases","volume":"17","author":"Cho","year":"2002","journal-title":"J Korean Med Sci"},{"key":"2021122708262352800_b8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2265.1991.tb00285.x","article-title":"Heterogeneity of circulating TSH-receptor antibodies in thyroid disease demonstrated directly by chromatography","volume":"34","author":"Worthington","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2021122708262352800_b9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0009-9120(92)90302-9","article-title":"Thyrotropin receptor antibodies: advances and importance of detection techniques in thyroid diseases","volume":"25","author":"Gupta","year":"1992","journal-title":"Clin Biochem"},{"key":"2021122708262352800_b10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.autrev.2010.08.018","article-title":"Bioassays for TSH-receptor autoantibodies: an update","volume":"10","author":"Lytton","year":"2010","journal-title":"Autoimmun Rev"},{"key":"2021122708262352800_b11","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1373\/clinchem.2007.100396","article-title":"Detection of thyroid-stimulating immunoglobulins by use of enzyme-fragment complementation","volume":"54","author":"Sandrock","year":"2008","journal-title":"Clin Chem"},{"key":"2021122708262352800_b12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0168-1656(02)00054-8","article-title":"Enhanced expression of exogenous genes from retroviruses using HIV2\/Tat","volume":"97","author":"Sandrock","year":"2002","journal-title":"J Biotechnol"},{"issue":"1","key":"2021122708262352800_b13","first-page":"S49","article-title":"Limit of blank, limit of detection and limit of quantitation","volume":"29","author":"Armbruster","year":"2008","journal-title":"Clin Biochem Rev"},{"key":"2021122708262352800_b14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"2021122708262352800_b15","first-page":"1758","article-title":"Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment","volume":"81","author":"Kim","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122708262352800_b16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0165-6147(99)01368-1","article-title":"GPCR\u2013Galpha fusion proteins: molecular analysis of receptor-G-protein coupling","volume":"20","author":"Seifert","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"2021122708262352800_b17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuint.2007.06.006","article-title":"Ligand screening system using fusion proteins of G protein-coupled receptors with G protein alpha subunits","volume":"51","author":"Suga","year":"2007","journal-title":"Neurochem Int"},{"key":"2021122708262352800_b18","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/nar\/13.7.2241","article-title":"Macromolecular crowding accelerates the cohesion of DNA fragments with complementary termini","volume":"13","author":"Zimmerman","year":"1985","journal-title":"Nucleic Acids Res"},{"key":"2021122708262352800_b19","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1210\/endo.137.11.8895321","article-title":"Evidence for negative cooperativity among human thyrotropin receptors overexpressed in mammalian cells","volume":"137","author":"Chazenbalk","year":"1996","journal-title":"Endocrinology"},{"key":"2021122708262352800_b20","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/340692a0","article-title":"GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours","volume":"340","author":"Landis","year":"1989","journal-title":"Nature"},{"key":"2021122708262352800_b21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tem.2007.05.002","article-title":"Modulation of TSHR signaling by posttranslational modifications","volume":"18","author":"Kursawe","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"2021122708262352800_b22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1081\/IAS-120015477","article-title":"Sensitive thyroid stimulating antibody (TSAb) assay using polyethylene glycol (PEG) \u2013 a review","volume":"23","author":"Ochi","year":"2002","journal-title":"J Immunoassay Immunochem"},{"key":"2021122708262352800_b23","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1210\/jc.2009-2470","article-title":"A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy","volume":"95","author":"Lytton","year":"2010","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2012.04648.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/170\/2\/115\/41907056\/cei4648.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/170\/2\/115\/41907056\/cei4648.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:24:07Z","timestamp":1641054247000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/170\/2\/115\/6429076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,5]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,10,5]]},"published-print":{"date-parts":[[2012,10,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2012.04648.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,11]]},"published":{"date-parts":[[2012,10,5]]}}}